Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Seres Therapeutics (MCRB) Q2 2024 Earnings
MCRB
-3.26%
8
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.5
-0.15
0.2
0.55
Details
Expected EPS
-0.341667
Actual EPS
-0.27
Surprise EPS
0.07
Surprise Percent
+20.98%
Description
Seres Therapeutics (MCRB) has reported earnings of -0.27 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login